Partner Content Partner Content Antibiotic Class Emerges through Digestive Enzyme SMi Group Reports: The official agenda and highlights
Partner Content Partner Content SMi’s Exclusive Interview with Mark Albrecht just released SMi Reports: An exclusive interview with Biomedical Adv
Events Partner Content Superbugs & Superdrugs USA Superbugs & Superdrugs USA November 12 – 13, 2018 New Jersey, USA
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
